Canada - English - Health Canada

bristol labs division of bristol-myers squibb - bleomycin sulfate - powder for solution - 15unit - bleomycin sulfate 15unit - antineoplastic agents

Canada - English - Health Canada

fresenius kabi canada ltd - bleomycin (bleomycin sulfate) - powder for solution - 15unit - bleomycin (bleomycin sulfate) 15unit - antineoplastic agents

Canada - English - Health Canada

sandoz canada incorporated - bleomycin (bleomycin sulfate) - powder for solution - 15unit - bleomycin (bleomycin sulfate) 15unit - antineoplastic agents

Malta - English - Medicines Authority

synthon hispania, s.l. calle castello 1, 08830 sant boi de llobregat, barcelona, spain - deferasirox - film-coated tablet - deferasirox 90 mg - all other therapeutic products

Malta - English - Medicines Authority

synthon hispania, s.l. calle castello 1, 08830 sant boi de llobregat, barcelona, spain - deferasirox - film-coated tablet - deferasirox 360 mg - all other therapeutic products

Malta - English - Medicines Authority

synthon hispania, s.l. calle castello 1, 08830 sant boi de llobregat, barcelona, spain - deferasirox - film-coated tablet - deferasirox 180 mg - all other therapeutic products

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma (m) sdn. bhd. - sevelamer carbonate -

Israel - English - Ministry of Health

taro international ltd, israel - dasatinib - film coated tablets - dasatinib 100 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.

Israel - English - Ministry of Health

taro international ltd, israel - dasatinib - film coated tablets - dasatinib 140 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.

Israel - English - Ministry of Health

taro international ltd, israel - dasatinib - film coated tablets - dasatinib 20 mg - dasatinib - dasatinib taro is indicated for the treatment of adult patients with: * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.